Clinical applications of serum markers for lung cancer.
D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D015816:Cell Adhesion Molecules, Neuronal / Q000097:blood; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood*; D008297:Male; D010455:Peptides / Q000097:blood; D010751:Phosphopyruvate Hydratase / Q000097:blood; D011379:Prognosis; D015375:Receptors, Interleukin-2 / Q000032:analysis; D015843:Serpins; D019396:Tissue Polypeptide Antigen
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D015816:Cell Adhesion Molecules, Neuronal; D053379:Chromogranin A; D002864:Chromogranins; D010455:Peptides; D015375:Receptors, Interleukin-2; D015843:Serpins; D019396:Tissue Polypeptide Antigen; C051072:squamous cell carcinoma-related antigen; D003402:Creatine Kinase; D010751:Phosphopyruvate Hydratase